BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND F

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a...

Related Keywords

China , Italy , Boston , Massachusetts , United States , Japan , Canada , London , City Of , United Kingdom , Italian , America , Chinese , Japanese , Lauren Tengler , Mike Mahoney , Kate Haranis , Boston Scientific Corporation , Boston Scientific , Nasdaq , Exchange Commission , Specialty Pharmaceuticals , Prnewswire Boston Scientific Corporation , Japanese Pharmaceuticals , Apollo Endosurgery Inc , Securities Exchange , Devices Agency , Acotec Scientific Holdings , Scientific Corporation , Middle East , Latin America , Medical Devices Agency , Drug Coated Balloon , Left Atrial Appendage Closure Device , Wavewriter Spinal Cord Stimulator Systems , Non Surgical Back , Virgin Back , Conventional Medical Management , Aortic Valve , Market Clinical Follow Up , Aortic Valve System , Interventional Advances , Apollo Endosurgery , Acotec Scientific Holdings Limited , Rhythm Management , Interventional Cardiology , Emerging Markets , Quarter Net Sales , Year Net Sales , Full Year , First Quarter , Statement Regarding Forward Looking Statements , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Quarterly Reports , Months Ended December , Mandatory Convertible Preferred Stock , Ended December , Before Income , Estimated Annual Effective Tax Rate , Financial Condition , Quarterly Report ,